TURBT
NEOADJUVANT
BEP 3 or 4 rounds
EP 4 round
BEP or EP, 20% have no adverse events (952 patients), the rest had one or more (42% 1-2; 26% 3-4, 13% more than 5). Most commonly tinnitus, hearing impairent, obesity and peripheral neuropathy with larger doses have more adverse events and similar number of adverse events after 3 BEP or 4 EP. (1)
IMMUNOTHERAPY
ADJUVANT
RADIATION
CYSTECTOMY
NEOADJUVANT
BEP 3 or 4 rounds
EP 4 round
BEP or EP, 20% have no adverse events (952 patients), the rest had one or more (42% 1-2; 26% 3-4, 13% more than 5). Most commonly tinnitus, hearing impairent, obesity and peripheral neuropathy with larger doses have more adverse events and similar number of adverse events after 3 BEP or 4 EP. (1)
IMMUNOTHERAPY
ADJUVANT
RADIATION
CYSTECTOMY